Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Cefpirome Treatment Results in Limited Selection of Stable Derepressed Enterobacter cloacae Mutants in the Intestinal Flora of Rats Treated for an Experimental Klebsiella pneumoniae Pulmonary Infection.

Gautam V, Mouton JW, Ten Kate MT, Bakker-Woudenberg IAJM, van Burgh S, Strepis N, Klaassen CHW, Goessens W.

Microb Drug Resist. 2019 Oct 29. doi: 10.1089/mdr.2018.0473. [Epub ahead of print]

PMID:
31657651
2.

Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles.

van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF.

Int J Antimicrob Agents. 2019 Aug;54(2):159-166. doi: 10.1016/j.ijantimicag.2019.05.019. Epub 2019 Jun 5.

PMID:
31173867
3.

Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.

Refos JM, Vonk AG, Ten Kate MT, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00960-17. doi: 10.1128/AAC.00960-17. Print 2018 Jan.

4.

Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.

Refos JM, Vonk AG, Ten Kate MT, Eadie K, Verbrugh HA, Bakker-Woudenberg IAJM, van de Sande WWJ.

PLoS One. 2017 Jul 24;12(7):e0180961. doi: 10.1371/journal.pone.0180961. eCollection 2017.

5.

Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.

Monteferrante CG, Sultan S, Ten Kate MT, Dekker LJ, Sparbier K, Peer M, Kostzrewa M, Luider TM, Goessens WH, Burgers PC.

J Antimicrob Chemother. 2016 Oct;71(10):2856-67. doi: 10.1093/jac/dkw208. Epub 2016 Jun 10.

PMID:
27287232
6.

Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.

Bax HI, Bakker-Woudenberg IA, Ten Kate MT, Verbon A, de Steenwinkel JE.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2577-9. doi: 10.1128/AAC.02864-15. Print 2016 Apr.

7.

Colistin as a potentiator of anti-TB drug activity against Mycobacterium tuberculosis.

Bax HI, de Steenwinkel JE, Ten Kate MT, van der Meijden A, Verbon A, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2015 Oct;70(10):2828-37. doi: 10.1093/jac/dkv194. Epub 2015 Jul 16.

PMID:
26183185
8.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Dec;94(6):701-7.

PMID:
25621361
9.

Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.

de Knegt GJ, Ten Kate MT, van Soolingen D, Aarnoutse R, Boeree MJ, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2014 Oct 13. pii: S1472-9792(14)20507-5. doi: 10.1016/j.tube.2014.09.002. [Epub ahead of print]

PMID:
25423883
10.

Evidence supporting a role for mammalian chitinases in efficacy of caspofungin against experimental aspergillosis in immunocompromised rats.

Verwer PE, ten Kate MT, Falcone FH, Morroll S, Verbrugh HA, Bakker-Woudenberg IA, van de Sande WW.

PLoS One. 2013 Oct 14;8(10):e75848. doi: 10.1371/journal.pone.0075848. eCollection 2013.

11.

Optimization of the rifampin dosage to improve the therapeutic efficacy in tuberculosis treatment using a murine model.

de Steenwinkel JE, Aarnoutse RE, de Knegt GJ, ten Kate MT, Teulen M, Verbrugh HA, Boeree MJ, van Soolingen D, Bakker-Woudenberg IA.

Am J Respir Crit Care Med. 2013 May 15;187(10):1127-34. doi: 10.1164/rccm.201207-1210OC.

PMID:
23525933
12.

Distinctive cytokines as biomarkers predicting fatal outcome of severe Staphylococcus aureus bacteremia in mice.

van den Berg S, Laman JD, Boon L, ten Kate MT, de Knegt GJ, Verdijk RM, Verbrugh HA, Nouwen JL, Bakker-Woudenberg IA.

PLoS One. 2013;8(3):e59107. doi: 10.1371/journal.pone.0059107. Epub 2013 Mar 8.

13.

Relapse of tuberculosis versus primary tuberculosis; course, pathogenesis and therapy in mice.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, Verbrugh HA, Hernandez-Pando R, Leenen PJ, Bakker-Woudenberg IA.

Tuberculosis (Edinb). 2013 Mar;93(2):213-21. doi: 10.1016/j.tube.2012.11.006. Epub 2012 Dec 23.

PMID:
23266260
14.

Rifampicin-induced transcriptome response in rifampicin-resistant Mycobacterium tuberculosis.

de Knegt GJ, Bruning O, ten Kate MT, de Jong M, van Belkum A, Endtz HP, Breit TM, Bakker-Woudenberg IA, de Steenwinkel JE.

Tuberculosis (Edinb). 2013 Jan;93(1):96-101. doi: 10.1016/j.tube.2012.10.013. Epub 2012 Nov 22.

PMID:
23182912
15.

The therapeutic effect of tigecycline, unlike that of Ceftazidime, is not influenced by whether the Klebsiella pneumoniae strain produces extended-spectrum β-lactamases in experimental pneumonia in rats.

Goessens WH, Mouton JW, Ten Kate MT, Sörgel F, Kinzig M, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2013 Jan;57(1):643-6. doi: 10.1128/AAC.01154-12. Epub 2012 Nov 5.

16.

Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, Aarnoutse RE, Boeree MJ, den Bakker MA, van Soolingen D, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2012 Sep;56(9):4937-44. doi: 10.1128/AAC.00124-12. Epub 2012 Jul 16.

17.

Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Kremer K, Aarnoutse RE, Boeree MJ, Verbrugh HA, van Soolingen D, Bakker-Woudenberg IA.

Emerg Infect Dis. 2012 Apr;18(4):660-3. doi: 10.3201/eid1804.110912.

18.

Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.

de Steenwinkel JE, ten Kate MT, de Knegt GJ, Verbrugh HA, van Belkum A, Hernandez-Pando R, Bakker-Woudenberg IA.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1478-84, i. doi: 10.5588/ijtld.11.0012.

PMID:
22008760
19.

Dynamics of interferon-gamma release assay and cytokine profiles in blood and respiratory tract specimens from mice with tuberculosis and the effect of therapy.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, Verbrugh HA, Ottenhoff TH, Bakker-Woudenberg IA.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1195-201. doi: 10.1007/s10096-011-1428-2. Epub 2011 Oct 9.

20.

Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis.

de Steenwinkel JE, de Knegt GJ, ten Kate MT, van Belkum A, Verbrugh HA, Kremer K, van Soolingen D, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2010 Dec;65(12):2582-9. doi: 10.1093/jac/dkq374. Epub 2010 Oct 14.

PMID:
20947621
21.

Immunological parameters to define infection progression and therapy response in a well-defined tuberculosis model in mice.

De Steenwinkel JE, De Knegt GJ, Ten Kate MT, Van Belkum A, Verbrugh HA, Hernandez-Pando R, Van Soolingen D, Bakker-Woudenberg IA.

Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):723-34.

PMID:
19822089
22.

Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.

van de Sande WW, Mathot RA, ten Kate MT, van Vianen W, Tavakol M, Rijnders BJ, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2009 May;53(5):2005-13. doi: 10.1128/AAC.01556-08. Epub 2009 Feb 23.

23.

Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.

van de Sande WW, van Vianen W, ten Kate MT, Vissers J, Laurijsens J, Tavakol M, Rijnders BJ, Mathot RA, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 2008 Apr;52(4):1345-50. doi: 10.1128/AAC.00536-07. Epub 2008 Jan 14.

24.

Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice.

de Steenwinkel JE, van Vianen W, Ten Kate MT, Verbrugh HA, van Agtmael MA, Schiffelers RM, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2007 Nov;60(5):1064-73. Epub 2007 Sep 10.

PMID:
17846106
25.

Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.

Goessens WH, Mouton JW, ten Kate MT, Bijl AJ, Ott A, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2007 Mar;59(3):507-16. Epub 2007 Feb 8.

PMID:
17289765
26.
27.

Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.

van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.

J Antimicrob Chemother. 2006 Apr;57(4):732-40. Epub 2006 Feb 7.

PMID:
16464895
28.

A murine model of Madurella mycetomatis eumycetoma.

Ahmed AO, van Vianen W, ten Kate MT, van de Sande WW, van Belkum A, Fahal AH, Verbrugh HA, Bakker-Woudenberg IA.

FEMS Immunol Med Microbiol. 2003 Jun 10;37(1):29-36.

29.

Liposome-enabled synergistic interaction of antimicrobial agents.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Liposome Res. 2002 Feb-May;12(1-2):121-7.

PMID:
12604045
30.

Ciprofloxacin in polyethylene glycol-coated liposomes: efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection.

Bakker-Woudenberg IA, ten Kate MT, Guo L, Working P, Mouton JW.

Antimicrob Agents Chemother. 2002 Aug;46(8):2575-81.

31.

In vivo synergistic interaction of liposome-coencapsulated gentamicin and ceftazidime.

Schiffelers RM, Storm G, ten Kate MT, Stearne-Cullen LE, den Hollander JG, Verbrugh HA, Bakker-Woudenberg IA.

J Pharmacol Exp Ther. 2001 Jul;298(1):369-75.

PMID:
11408564
32.

Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.

Bakker-Woudenberg IA, ten Kate MT, Guo L, Working P, Mouton JW.

Antimicrob Agents Chemother. 2001 May;45(5):1487-92.

33.
34.

Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

van Etten EW, ten Kate MT, Snijders SV, Bakker-Woudenberg IA.

Antimicrob Agents Chemother. 1998 Jul;42(7):1677-81.

35.
36.

Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis.

Leenders AC, de Marie S, ten Kate MT, Bakker-Woudenberg IA, Verbrugh HA.

J Antimicrob Chemother. 1996 Aug;38(2):215-25.

PMID:
8877535
37.
38.

Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages.

Daemen T, Hofstede G, Ten Kate MT, Bakker-Woudenberg IA, Scherphof GL.

Int J Cancer. 1995 May 29;61(5):716-21.

PMID:
7768646
39.
40.

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

van Etten EW, Otte-Lambillion M, van Vianen W, ten Kate MT, Bakker-Woudenberg AJ.

J Antimicrob Chemother. 1995 Apr;35(4):509-19.

PMID:
7628985
41.

Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Mouton JW, Woodle MC, Storm G.

J Infect Dis. 1993 Jul;168(1):164-71.

PMID:
8515105
42.

Liposomes as carriers of antimicrobial agents or immunomodulatory agents in the treatment of infections.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Melissen PM, van Vianen W, van Etten EW.

Eur J Clin Microbiol Infect Dis. 1993;12 Suppl 1:S61-7. Review.

PMID:
8477767
43.

Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue.

Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Storm G.

Biochim Biophys Acta. 1992 Apr 14;1138(4):318-26.

PMID:
1532911

Supplemental Content

Loading ...
Support Center